The C-Brace® microprocessor controlled stance and swing orthosis improves safety, mobility, and quality of life at one year: Interim results from a prospective registry.

Autor:	Lundstrom RL; Department of Clinical Research & Services, Otto Bock Healthcare LP, Austin, TX, USA., Klenow TD; Department of Clinical Research & Services, Otto Bock Healthcare LP, Austin, TX, USA., Morris A; Department of Clinical Research & Services, Otto Bock Healthcare LP, Austin, TX, USA., Pobatschnig B; Department of Clinical Research & Services, Ottobock Healthcare Products GmbH, Vienna, AT, USA., Hibler KD; Department of Statistical Innovation, Independent Statistician, Bradenton, FL, USA., Kannenberg AH; Department of Clinical Research & Services, Otto Bock Healthcare LP, Austin, TX, USA.
Jazyk:	angličtina
Zdroj:	Journal of rehabilitation and assistive technologies engineering [J Rehabil Assist Technol Eng] 2024 Aug 09; Vol. 11, pp. 20556683241269539. Date of Electronic Publication: 2024 Aug 09 (Print Publication: 2024).
DOI:	10.1177/20556683241269539
Abstrakt:	Introduction: The C-Brace microprocessor-controlled stance and swing control orthosis has been shown to improve function, mobility, and quality of life. A systematic registry to gather long-term, real-world safety and effectiveness data in patients fit with a C-Brace has not been performed. Methods: International multicenter registry. Patients undergoing routine C-Brace fittings were assessed at baseline and 1 year after fitting. Primary outcomes were fast walking speed (FWS) measured by 25-foot or 10-meter walk test, Timed Up and Go (TUG) and the Activity-specific Balance Confidence (ABC) Scale. Secondary and exploratory outcomes included the Patient-specific Functional Scale (PSFS), falls, pain, PROMIS Pain Interference (PI), and quality of life. Results: 48 subjects with 1-year baseline and follow up data were analyzed. With the C-Brace, FWS improved by + 0.26 ± 0.33 m/s ( p < .0001), TUG by -8.1 ± 14.6 sec ( p < .0001), and ABC by + 24.9 ± 25.8% ( p < .0001). Mean falls reduced from 33 ± 77 to 3.0 ± 5.6 ( p = .0005). PSFS increased by 3.60 ± 2.34 points ( p < .0001). Outcomes for pain, PI and quality of life showed significant improvements with the C-Brace. Conclusion: The C-Brace is an effective option to improve safety, mobility, and quality of life for patients needing a KAFO for ambulation. Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: RL, TK, AM, BP, & AK are employees of subsidiary companies of Ottobock SE & Co. KGaA, the manufacturer of the C-Brace. KH has received consultancies from Otto Bock HealthCare LP. (© The Author(s) 2024.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu